Rein Therapeutics, Inc.
RNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420565
No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Rein Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +4 vs. Q2 2024
- Shares held
- 4.61M
- −258.1K (−5.3%) vs. Q2 2024
- Total value
- $16.3M
- +$2.88M (+21.5%) vs. Q2 2024
- New holders
- 6
- 5 more added
- Sold out
- 2
- 8 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $42.3M |
| Q1 2026 | 46 | $14.8M |
| Q4 2025 | 48 | $12.5M |
| Q3 2025 | 40 | $9.76M |
| Q2 2025 | 36 | $9.30M |
| Q1 2025 | 39 | $10.6M |
| Q4 2024 | 31 | $13.1M |
| Q3 2024 | 32 | $16.3M |
| Q2 2024 | 29 | $13.5M |
| Q1 2024 | 23 | $11.0M |
| Q4 2023 | 20 | $3.24M |
| Q3 2023 | 16 | $1.59M |
| Q2 2023 | 17 | $1.83M |
| Q1 2023 | 19 | $1.30M |
| Q4 2022 | 19 | $3.21M |
| Q3 2022 | 33 | $5.86M |
| Q2 2022 | 37 | $8.34M |
| Q1 2022 | 42 | $16.5M |
| Q4 2021 | 43 | $18.9M |
| Q3 2021 | 43 | $33.6M |
| Q2 2021 | 47 | $41.5M |
| Q1 2021 | 52 | $48.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 17 | $0 | 0.00% | 00.0% | Unchanged |
| Avion Wealth | 200 | $0 | 0.00% | +200 | New |
| Game Plan Financial Advisors, LLC | 25 | $89 | 0.00% | 00.0% | Unchanged |
| Hexagon Capital Partners LLC | 213 | $754 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 233 | $825 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 243 | $860 | 0.00% | −3,621−93.7% | Reduced |
| Bank of America Corp | 285 | $1.01K | 0.00% | −7−2.4% | Reduced |
| Sachetta, LLC | 1,000 | $3.54K | 0.00% | +1,000 | New |
| US Bancorp | 1,250 | $4.42K | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 1,590 | $5.63K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,550 | $19.6K | 0.00% | +4,300+344.0% | Added |
| Royal Bank of Canada | 8,000 | $28.0K | 0.00% | −52,241−86.7% | Reduced |
| Wells Fargo & Company | 9,544 | $33.8K | 0.00% | +9,544 | New |
| Warberg Asset Management LLC | 10,000 | $35.4K | 0.01% | −21,354−68.1% | Reduced |
| State Street Corp | 10,404 | $36.8K | 0.00% | 00.0% | Unchanged |
| KG&L Capital Management,LLC | 13,000 | $46.0K | 0.01% | +13,000 | New |
| Renaissance Technologies LLC | 13,164 | $46.6K | 0.00% | −11,700−47.1% | Reduced |
| Newbridge Financial Services Group, Inc. | 25,000 | $88.5K | 0.03% | +25,000 | New |
| Blair William & Co | 25,602 | $90.6K | 0.00% | −2,445−8.7% | Reduced |
| Northern Trust Corp | 25,763 | $91.2K | 0.00% | 00.0% | Unchanged |
| Texas Capital Bank Wealth Management Services Inc | 26,171 | $92.6K | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 51,280 | $181.5K | 0.00% | +51,280 | New |
| Gagnon Securities LLC | 71,761 | $254.0K | 0.05% | +33,784+89.0% | Added |
| Sigma Planning Corp | 212,410 | $751.9K | 0.02% | +86,185+68.3% | Added |
| Senvest Management, LLC | 230,895 | $801.0K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 229,817 | $813.8K | 0.00% | +59,370+34.8% | Added |
| Prosight Management, LP | 372,157 | $1.32M | 0.33% | +107,157+40.4% | Added |
| Cable Car Capital LLC | 420,000 | $1.49M | 1.60% | 00.0% | Unchanged |
| Vanguard Group Inc | 432,201 | $1.53M | 0.00% | −73,952−14.6% | Reduced |
| Nantahala Capital Management, LLC | 464,367 | $1.64M | 0.14% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 540,000 | $1.91M | 0.01% | 00.0% | Unchanged |
| University of Texas/Texas Am Investment Managment Co | 1,403,339 | $4.97M | 0.81% | −374,488−21.1% | Reduced |
| Kepos Capital LP | 0 | $0 | 0.00% | −106,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,145−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |